Life Sciences and Healthcare

Life sciences & Healthcare Subtitle

Currently, on an upward growth curve, the life science and healthcare industry has seen immense growth since liberalisation in the 1990s. An increasingly affluent population is spending on private healthcare, and Indian pharma and biotech companies are increasing investments and growing internationally. India has a substantial life science manufacturing presence, it currently supplies over 50% of global demand for various vaccines and supplies approximately 25% of all medicine in the UK. The size of the Indian healthcare sector is expected to cross USD 133 billion by 2022. Furthermore, Delivering Ayushman Bharat, the world’s largest government funded healthcare insurance scheme, could potentially benefit over half a billion people in India. Indian government recently permitted FDI up to 100% under the automatic route for manufacturing of medical devices and the liberalisation of the insurance industry in India will also boost healthcare insurance.

Read our latest report

Latest News

Case studies

View More

Get a free consultation with one of our India Advisers